| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are we ABL to do better for children with BCR–ABL1-like acute lymphocytic leukaemia?
|
Tasian, Sarah K
|
|
|
8 |
1 |
p. e6-e8
|
artikel
|
| 2 |
2020 ASH Annual Meeting
|
Cookson, Emma
|
|
|
8 |
1 |
p. e16-e17
|
artikel
|
| 3 |
A thank you to our peer reviewers of 2020
|
Smith, Lan-Lan
|
|
|
8 |
1 |
p. e10-e11
|
artikel
|
| 4 |
Bishesh Poudyal: transplantation at a lifesaving discount
|
Cavanaugh, Ray
|
|
|
8 |
1 |
p. e19
|
artikel
|
| 5 |
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial
|
Usmani, Saad Z
|
|
|
8 |
1 |
p. e45-e54
|
artikel
|
| 6 |
Dabigatran etexilate and treatment of acute venous thromboembolism in children
|
Kenet, Gili
|
|
|
8 |
1 |
p. e2-e3
|
artikel
|
| 7 |
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial
|
Halton, Jacqueline
|
|
|
8 |
1 |
p. e22-e33
|
artikel
|
| 8 |
High-risk myeloma: a challenge to define and to determine the optimal treatment
|
Pawlyn, Charlotte
|
|
|
8 |
1 |
p. e4-e6
|
artikel
|
| 9 |
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial
|
Ladetto, Marco
|
|
|
8 |
1 |
p. e34-e44
|
artikel
|
| 10 |
Multiple keratoacanthomas in a patient with myelodysplastic syndrome
|
Zhu, Peiqiu
|
|
|
8 |
1 |
p. e94
|
artikel
|
| 11 |
NICE guidance on caplacizumab for treating acute acquired thrombotic thrombocytopenia purpura
|
Hughes, Mary
|
|
|
8 |
1 |
p. e14-e15
|
artikel
|
| 12 |
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
|
den Boer, Monique L
|
|
|
8 |
1 |
p. e55-e66
|
artikel
|
| 13 |
Should individuals who have been cured of hepatitis C virus and their partners be allowed to donate blood?
|
Aghemo, Alessio
|
|
|
8 |
1 |
p. e8-e10
|
artikel
|
| 14 |
Targeted leukaemia therapy: a chemotherapy-free future?
|
The Lancet Haematology,
|
|
|
8 |
1 |
p. e1
|
artikel
|
| 15 |
The M factor: maintenance in mantle cell lymphoma
|
Dreyling, Martin
|
|
|
8 |
1 |
p. e3-e4
|
artikel
|
| 16 |
The role of PET in first-line treatment of Hodgkin lymphoma
|
Trotman, Judith
|
|
|
8 |
1 |
p. e67-e79
|
artikel
|
| 17 |
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
|
Barrington, Sally F
|
|
|
8 |
1 |
p. e80-e93
|
artikel
|
| 18 |
The state of haematopoietic cells transplantation in Latin America
|
Jaimovich, Gregorio
|
|
|
8 |
1 |
p. e20-e21
|
artikel
|
| 19 |
Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria
|
Watson, James A
|
|
|
8 |
1 |
p. e12
|
artikel
|
| 20 |
Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria – Authors' reply
|
Ackerman, Hans
|
|
|
8 |
1 |
p. e12-e13
|
artikel
|
| 21 |
Women with haemophilia also exist
|
Pascual, Ana
|
|
|
8 |
1 |
p. e18
|
artikel
|
Tijdschrift beschrijving